Nutrition 21's (NXX) Selenomax Suppresses Progression of HIV-1 According to Study Results

January 22, 2007 5:40 PM EST Send to a Friend
Nutrition 21, Inc. (NASDAQ: NXXI) announced that daily supplementation with Selenomax, the company's high selenium yeast product, suppressed progression of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login